Women & Infants earns recognition from The Joint Commission
Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in the U.S.
Women & Infants was recognized as part of The Joint Commission's 2015 annual report "America's Hospitals: Improving Quality and Safety," for attaining and sustaining excellence in accountability measure performance for perinatal care. Women & Infants is one of only two hospitals in Rhode Island and 1,043 hospitals out of more than 3,300 eligible hospitals in the U.S. to achieve the 2014 Top Performer distinction.
"We are so proud of this honor and to be recognized among some of the best hospitals in our country," said Mark R. Marcantano, president and chief operating officer, Women & Infants Hospital. "This distinction as a Top Performer by The Joint Commission is recognition of our organization's continuous focus on improving the safety and the quality of the care that we provide to the women and newborns of our region."
The Top Performer program recognizes hospitals for improving performance on evidence-based interventions that increase the chances of healthy outcomes for patients with certain conditions. The performance measures included in the recognition program include heart attack, heart failure, pneumonia, surgical care, children's asthma, inpatient psychiatric services, stroke, venous thromboembolism, perinatal care, immunization, tobacco treatment, and substance abuse.
To be a 2014 Top Performer, hospitals had to meet three performance criteria based on 2014 accountability measure data, including:
- Achieve cumulative performance of 95 percent or above across all reported accountability measures;
- Achieve performance of 95 percent or above on each and every reported accountability measure with at least 30 denominator cases; and
- Have at least one core measure set that had a composite rate of 95 percent or above, and within that measure set, achieve a performance rate of 95 percent or above on all applicable individual accountability measures.
"Delivering the right treatment in the right way at the right time is a cornerstone of high quality health care. I commend the efforts of Women & Infants Hospital for their excellent performance on the use of evidence-based interventions," said Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, The Joint Commission.
About Women & Infants Hospital
Women & Infants Hospital of Rhode Island, a Care New England hospital, is one of the nation's leading specialty hospitals for women and newborns. A major teaching affiliate of The Warren Alpert Medical School of Brown University for obstetrics, gynecology and newborn pediatrics, as well as a number of specialized programs in women's medicine, Women & Infants is the 11th largest stand-alone obstetrical service in the country with approximately 8,400 deliveries per year. A U.S.News 2014-15 Best Children's Hospital in Neonatology, in 2009 Women & Infants opened the country's largest, single-family room neonatal intensive care unit.
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation's only mother-baby perinatal psychiatric partial hospital, as well as the nation's only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Center of Excellence the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center for In Vitro Maturation Excellence by SAGE In Vitro Fertilization; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute's Gynecologic Oncology Group and the Pelvic Floor Disorders Network.